Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) traded at $0.58 at close of the session on Tuesday, April 09, made a downward move of -20.21% on its previous day’s price.
Looking at the stock we see that its previous close was $0.73 and the beta (5Y monthly) reads 0.21 . In terms of its 52-week price range, BCLI has a high of $3.37 and a low of $0.13. The company’s stock has gained about 76.52% over that past 30 days.
Brainstorm Cell Therapeutics, Inc. has a market cap of $39.81 million and is expected to release its quarterly earnings report on May 13, 2024 – May 17, 2024. Estimates by analysts give the company expected earnings per share (EPS) of $0, with the EPS growth for the year raised at -$0.7 for 2023 and -$0.47 for next year. These figures represent -6.10% and 32.90% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the BCLI stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of Hold.
Looking further, we note the current price level is 10.38% off its SMA20 and 36.64% from its 50-day simple moving average. The RSI (14) is pointing at 53.71 while the volatility over the past week is 14.34% and jumps to 19.98% over the past one month. The beta value is 0.26, while the average true range (ATR) is currently pointing at 0.09.
Coming back to Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI), we note that the average 3-month trading volume was 962.07K, while that of the preceding 10-day period stands at 1.54 million. Current shares outstanding are 60.49 million.
The insiders hold 17.86% of the company’s shares while institutions hold 5.80%. The data shows that short shares as of Mar 15, 2024, stood at 0.85 million at a short ratio of 1.32. This represents a 1.74% short interest in shares outstanding on Mar 15, 2024. Shares short fall in March from the previous month at 1.23 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 113.37% up in year-to-date price movement.
